🇺🇸 FDA
Patent

US 11241478

Adenovirus-associated viral vectors for expressing variants of tetratricopeptide repeat (TPR)-containing Rab8b interacting (TRIP8b) protein in neurons and uses thereof for treating major depressive disorder (MDD)

granted A61KA61K38/00A61K38/16

Quick answer

US patent 11241478 (Adenovirus-associated viral vectors for expressing variants of tetratricopeptide repeat (TPR)-containing Rab8b interacting (TRIP8b) protein in neurons and uses thereof for treating major depressive disorder (MDD)) held by Northwestern University expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Feb 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K38/00, A61K38/16, A61P, A61P25/24